Epoxyeicosatrienoic Acids Regulate Adipocyte Differentiation of Mouse 3T3 Cells, Via PGC-1α Activation, Which Is Required for HO-1 Expression and Increased Mitochondrial Function
Overview
Authors
Affiliations
Epoxyeicosatrienoic acid (EET) contributes to browning of white adipose stem cells to ameliorate obesity/diabetes and insulin resistance. In the current study, we show that EET altered preadipocyte function, enhanced peroxisome proliferation-activated receptor γ coactivator α (PGC-1α) expression, and increased mitochondrial function in the 3T3-L1 preadipocyte subjected to adipogenesis. Cells treated with EET resulted in an increase, P < 0.05, in PGC-1α and a decrease in mitochondria-derived ROS (MitoSox), P < 0.05. The EET increase in heme oxygenase-1 (HO-1) levels is dependent on activation of PGC-1α as cells deficient in PGC-1α (PGC-1α knockout adipocyte cell) have an impaired ability to express HO-1, P < 0.02. Additionally, adipocytes treated with EET exhibited an increase in mitochondrial superoxide dismutase (SOD) in a PGC-1α-dependent manner, P < 0.05. The increase in PGC-1α was associated with an increase in β-catenin, P < 0.05, adiponectin expression, P < 0.05, and lipid accumulation, P < 0.02. EET decreased heme levels and mitochondria-derived ROS (MitoSox), P < 0.05, compared to adipocytes that were untreated. EET also decreased mesoderm-specific transcript (MEST) mRNA and protein levels (P < 0.05). Adipocyte secretion of EET act in an autocrine/paracrine manner to increase PGC-1α is required for activation of HO-1 expression. This is the first study to dissect the mechanism by which the antiadipogenic and anti-inflammatory lipid, EET, induces the PGC-1α signaling cascade and reprograms the adipocyte phenotype by regulating mitochondrial function and HO-1 expression, leading to an increase in healthy, that is, small, adipocytes and a decrease in adipocyte enlargement and terminal differentiation. This is manifested by an increase in mitochondrial function and an increase in the canonical Wnt signaling cascade during adipocyte proliferation and terminal differentiation.
Study insights in the role of PGC-1α in neurological diseases: mechanisms and therapeutic potential.
Tang M, Liu Y, Hu Z, Luo H, Zhang S, Shi C Front Aging Neurosci. 2025; 16:1454735.
PMID: 40012862 PMC: 11861300. DOI: 10.3389/fnagi.2024.1454735.
Yousef A, Fang L, Heidari M, Kranrod J, Seubert J Front Pharmacol. 2024; 15:1486717.
PMID: 39703395 PMC: 11655241. DOI: 10.3389/fphar.2024.1486717.
Hidayat R, El-Ghiaty M, Shoieb S, Alqahtani M, El-Kadi A Eur J Drug Metab Pharmacokinet. 2023; 48(6):709-722.
PMID: 37815672 DOI: 10.1007/s13318-023-00857-1.
Fujimaki A, Ohuchi K, Takizawa S, Murakami T, Kurita H, Hozumi I Sci Rep. 2023; 13(1):15629.
PMID: 37731009 PMC: 10511692. DOI: 10.1038/s41598-023-42903-7.
Lycopene improves autophagy and attenuates carbon tetrachloride-induced hepatic fibrosis in rats.
Li W, Jiang Y, Yu T, Hao W, Wang G Croat Med J. 2023; 64(4):243-255.
PMID: 37654036 PMC: 10509677.